| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 12.973 | 42.954 | 54.239 | 54.668 | 57.546 | 68.199 | 81.098 | 86.748 |
| Total Income - EUR | - | - | 13.644 | 45.182 | 56.903 | 59.529 | 60.302 | 71.575 | 84.375 | 87.689 |
| Total Expenses - EUR | - | - | 10.716 | 26.389 | 29.402 | 33.568 | 39.739 | 42.377 | 45.303 | 46.514 |
| Gross Profit/Loss - EUR | - | - | 2.927 | 18.793 | 27.501 | 25.961 | 20.563 | 29.199 | 39.072 | 41.175 |
| Net Profit/Loss - EUR | - | - | 2.791 | 18.341 | 26.932 | 25.422 | 20.032 | 28.497 | 38.245 | 38.597 |
| Employees | - | - | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 2 |
Check the financial reports for the company - Amethist Medcos Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 7.686 | 6.523 | 4.768 | 5.107 | 3.777 | 5.578 |
| Current Assets | - | - | 4.476 | 20.262 | 27.393 | 31.181 | 36.172 | 27.904 | 39.094 | 37.931 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 2.399 | 3.475 | 4.527 | 5.428 | 4.901 | 6.519 | 23.412 | 15.676 |
| Cash | - | - | 2.077 | 16.787 | 22.866 | 25.753 | 31.271 | 21.386 | 15.682 | 22.255 |
| Shareholders Funds | - | - | 2.835 | 18.393 | 26.983 | 30.132 | 38.856 | 29.053 | 38.294 | 38.645 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.641 | 1.869 | 8.096 | 7.572 | 2.084 | 3.958 | 4.577 | 4.863 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Amethist Medcos Srl